Text size Photograph by JOSEPH PREZIOSO / AFP via Getty Images The Modern biotechnology company, which has received commitments of nearly $ 1 billion from the federal government to develop its Covid-19 vaccine, seeks to sell the vaccine for between $ 25 and $ 30 per dose, the Financial Times …
Read More »
Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna. . That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems …
Read More »
Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
Text size Maddie Meyer / Getty Images Moderna on Thursday lost a patent case that had been almost entirely overlooked as the stock increased due to excitement over the company’s Covid-19 vaccine, which will be tested in a large Phase 3 trial to begin. next week. What the decision issued …
Read More »
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »